home / openregs / legislation

legislation: 99-s-2407

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
99-s-2407 99 s 2407 Animal Drug Amendments and Patent Term Restoration Act of 1986 Health 1986-05-06 1986-09-17 Placed on Senate Legislative Calendar under General Orders. Calendar No. 919. Senate Sen. Hatch, Orrin G. [R-UT] UT R H000338 1 (Reported to Senate from the Committee on Labor and Human Resources with amendment, S. Rept. 99-448) Animal Drug Amendments and Patent Term Restoration Act of 1986 - Title I: Animal Drug Amendments - Amends the Federal Food, Drug, and Cosmetic Act to authorize abbreviated applications for the approval of a new animal drug. Requires the applicant to file with the application (or amend it when the information becomes available) the patent number and the expiration date of any patent which covers the drug or a method of using it and with respect to which a claim of patent infringement could reasonably be asserted if a non-licensee engaged in the drug's manufacture, use, or sale. Requires such application to show that permitted uses and ingredients, labeling, and other factors are the same as or bioequivalent to a drug already approved, including the withdrawal period, proof of which may require a tissue residue study in more than one species. Requires such application to contain a certification relating to patents covering such listed drug. Requires an applicant who makes such a certification to state in the application that a specified notice has been given to each owner of the patent (or owner-representative) and the holder (or holder-representative) of the approved application for the drug or drug use claimed by the patent. Sets forth information to be included in such notice. Requires the permission of the Secretary of Health and Human Services before an abbreviated application may be submitted for a new drug which has a different active ingredient or whose route of administration, dosage form, or strength differ from that of an approved animal drug. Directs the Secretary to approve an application for such a drug unless specified findings are made. Requires the Secretary to approve or disapprove an application within a specified time. Sets forth a formula for determining when an approved application becomes effective based upon the nature of the certification relating to patents. Prohibits an abbreviated application for a new animal drug based upon a non-abbreviated application approved after this Act's enactment until five years after the non-abbreviated application is approved, except as specified. Requires a three year wait for abbreviated applications based upon non-abbreviated applications approved after this Act's enactment which contain essential new investigations of an ingredient already approved. Requires the Secretary to disapprove the application if it does not contain certain patent information, or to withdraw approval if the patent information was not filed within a specified time after notification. Requires disapproval if substantial evidence of scientific particulars is missing or inadequate. Requires the approval of a drug to be withdrawn or suspended if the application for approval was abbreviated and it refers to a drug the approval of which was withdrawn or suspended for specific reasons. Requires the publication of the reasons for such action. Provides for the promulgation of regulations to administer the amendments made by this title. Title II: Patent Extension - Amends the patent laws to include veterinary drugs and biologics under the patent extension provisions applicable to human drugs which compensate for regulatory delays. 2025-04-21T12:24:17Z  

Links from other tables

  • 7 rows from bill_id in legislation_actions
  • 10 rows from bill_id in legislation_subjects
  • 1 row from bill_id in legislation_cosponsors
  • 0 rows from bill_id in cbo_cost_estimates
Powered by Datasette · Queries took 1.205ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API